UC San Diego Health has developed the first blood test for testicular cancer available in the U.S., according to an announcement. The test, the product of ten years of research, aids precision medicine in testicular cancer patients.
Cases of vector-borne diseases have increased significantly since 2004, with more than 1 million cases reported between 2001 and 2023 in the United States. Early detection is key to outbreak control. PCR remains the gold standard for accurate, reliable detection.
Recent findings from the University of South Australia and Flinders University discovered a connection between certain daily medications and poor breast cancer outcomes. Details about the study are summarized in a press release.
The American Cancer Society (ACS) has published their first edition of The U.S. Tobacco Atlas. Key findings from the report are summarized in a press release.
The landscape of vaginitis testing is evolving, and laboratories have an opportunity to lead the way by embracing more accurate guideline-based approaches. This represents a critical step toward reducing unnecessary antibiotic use and curbing the spread of STIs.
Resilience requires more than reacting to crises. It means preparing for the unexpected and protecting patient care. Join our 11/13 webinar to learn about tools to navigate the essential shift beyond cost efficiency to embrace risk resilience as a strategic imperative.
